Specific GLP-1 receptor agonists (liraglutide, semaglutide, dulaglutide) have demonstrated cardiovascular benefits in people with type 2 diabetes who have established cardiovascular disease or high cardiovascular risk
Elevated Blood Sugar Levels : Discontinuing GLP-1 medications can result in fluctuations in blood sugar, which may impact energy levels and mood
By supporting acetylcholine levels, ALCAR may help improve vagal tone, thereby understanding the mechanisms of dysautonomia and providing a stabilizing effect on the autonomic nervous system
While results have been mixed, research continues to explore optimal dosing strategies and timing for potential ergogenic effects
That bowl of pasta just used up 40% of your daily calories and gave you almost no protein
Theres research not widely discussed in consumer health circles suggesting that NAD+ doesnt just patch the side effects of GLP-1 medications